|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Safety and efficacy of a triphasic oral contraceptive containing |
| desogestrel: results of three multicenter trials. |
| CONTRACEPTION. 1993 Oct;48(4):323-37. |
| This report combines the data obtained in 3 multicenter efficacy studies with a new triphasic oral contraceptive (OC) |
| combination containing desogestrel (DSG) and ethinyl estradiol (EE). The studies were conducted at 40 |
| investigational sites in the US (38 centers) and Canada (2 centers) in support of the US Food and Drug |
| Administration approval of the product. In total, 1095 subjects were exposed to the study medication for 11,231 |
| cycles, corresponding to approximately 864 woman-years of use. Of these subjects, 414 completed at least 13 |
| cycles of treatment. Contraceptive efficacy was high; 6 pregnancies occurred during the in-treatment period (2 due to |
| method failure and 4 due to user failure), corresponding to Pearl Indices of 0.23 and 0.46, respectively. The |
| incidence of irregular bleeding was low, and the acceptability was excellent as evidenced by the low incidence of |
| drug-related dropouts. No drug-related serious adverse experiences were reported, and the incidence of other drug- |
| related adverse experiences was generally low and decreased with continued use. No effects were seen on blood |
| pressure, body mass index, laboratory parameters, cervical cytology, and breast nodularity. These studies |
| demonstrate that triphasic DSG/EE is an effective and acceptable triphasic OC preparation with excellent cycle |
| control and no significant physiologic effects. (PubHealth.info Document ID: CONT2T 4572-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Safety and efficacy of a triphasic oral contraceptive |
| containing desogestrel: results of three multicenter trials.", is(are) Darney P. The source of this article is |
| "CONTRACEPTION. 1993 Oct;48(4):323-37.". This article was published in 1993 in English language(s). |
| (PubHealth.info® Document ID: CONT2T 4572-06. All rights reserved with PubHealth.info) PIN: 9572 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |